Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Type 1 selected

Type

Guidance programme

Showing 1 to 10 of 23

TitleReference numberPublishedLast updated
Fruquintinib for previously treated metastatic colorectal cancerTA1079
Nivolumab plus ipilimumab for untreated unresectable or metastatic colorectal cancer with high microsatellite instability or mismatch repair deficiencyTA1065
Trifluridine–tipiracil with bevacizumab for treating metastatic colorectal cancer after 2 systemic treatmentsTA1008
Pembrolizumab for previously treated endometrial, biliary, colorectal, gastric or small intestine cancer with high microsatellite instability or mismatch repair deficiencyTA914
Quantitative faecal immunochemical testing to guide colorectal cancer pathway referral in primary careHTG690
Intraoperative electron beam radiotherapy for locally advanced and locally recurrent colorectal cancerHTG681
Regorafenib for previously treated metastatic colorectal cancerTA866
Colorectal cancer prevention: colonoscopic surveillance in adults with ulcerative colitis, Crohn's disease or adenomasCG118
Colorectal cancerNG151
Nivolumab with ipilimumab for previously treated metastatic colorectal cancer with high microsatellite instability or mismatch repair deficiencyTA716

Results per page

  1. 10
  2. 25
  3. 50
  4. All